Cerebral Aneurysm Management Market Will Generate Booming Growth Opportunities to 2033Posted by Ganesh Shinde on March 21st, 2023  The global cerebral aneurysm management market is predicted to generate a market value of US$ 1.56 billion in 2023 and a market value of US$ 2.98 billion by 2023 to 2033, at a CAGR of 6.7%. The rise in the elderly population and the availability of various treatments to treat the ailment might be contributed to the growth of the cerebral aneurysm management market. In the historical period 2018 to 2022, the market for cerebral aneurysm management grew at a CAGR of 4%. The growth of the cerebral aneurysm treatment market is driven by the increasing number of individuals with cerebrovascular disorders globally. Factors such as a rise in patients with high blood pressure, trauma to blood vessels, and unhealthy lifestyle habits like smoking contribute to the growth of the market. The increasing use of medical therapies for treating un-ruptured intracranial aneurysms, advancements in neurodegenerative disease drug discovery, and an increase in cigarette smokers responsible for brain cancer also play a role. The improving healthcare infrastructure, increase in healthcare expenditure, and ongoing research and development efforts further boost the market. The market outlook for 2023 to 2033 is favorable, with opportunities for growth due to innovations in drugs and treatment options. Furthermore, North America and Europe are expected to be major contributors for the development of Cerebral aneurysm management market owing to the prevalence of geriatric population and technologically advanced healthcare infastructures. Competitive Landscape Key players in the cerebral aneurysm management market are Biogen, Pfizer Inc, Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp, Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Corporation, UCB S.A., Acadia Pharmaceuticals Inc, Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation Get More Details@ https://www.futuremarketinsights.com/reports/cerebral-aneurysm-management-market Key Segments Profiled in the Cerebral Aneurysm Management Market Survey Drug Class:
Route of Administration:
Distribution Channel:
Like it? Share it! More by this author |